Zuletzt veröffentlichtes Transkript: Reata Pharmaceuticals, Inc.
Manager | Titel | Alter | Seit |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01.09.22 |
Director of Finance/CFO | 60 | 26.09.23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01.09.22 |
Director/Board Member | - | 26.09.23 | |
Michael Dambach
BRD | Director/Board Member | - | 26.09.23 |
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,10% | 0 M€ | 0.00% | - | |
0,07% | 0 M€ | 0.00% | - | |
0,05% | 773 M€ | -.--% | - | |
0,04% | 509 M€ | -.--% |
% 1. Jan. | Kap. | |
---|---|---|
-2.26% | 103 Mrd. | |
+1.41% | 95.71 Mrd. | |
+0.79% | 22.02 Mrd. | |
-17.84% | 20.9 Mrd. | |
-9.37% | 17.85 Mrd. | |
-42.83% | 16.21 Mrd. | |
-17.63% | 15.52 Mrd. | |
+4.55% | 13.86 Mrd. | |
+32.11% | 12.04 Mrd. |